Market Size of Global Continuous Manufacturing Industry
Study Period | 2019 - 2029 |
Base Year For Estimation | 2023 |
Forecast Data Period | 2024 - 2029 |
CAGR | 12.80 % |
Fastest Growing Market | Asia Pacific |
Largest Market | North America |
Major Players*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Continuous Manufacturing Market Analysis
The continuous manufacturing market is projected to register a CAGR of 12.8% during the forecast period (2022 - 2027).
The sudden onset of Covid-19 resulted in high demand for pharmaceuticals. The imposition of strict lockdowns across the globe resulted in the lack of labor and supply thereby resulting in the huge demand for pharmaceuticals. Hence, the COVID-19 pandemic led to increasing demand for continuous manufacturing, thereby contributing to the growth of the market. For instance, the article titled "The pandemic effect: making continuous manufacturing a reality" published in September 2021 mentioned that with the ongoing COVID-19 pandemic and the increasing demand for low-cost vaccines and other pandemic-related treatments at an all-time high, big pharmaceutical companies are stepping up efforts to make continuous manufacturing a reality. Thus, the outbreak of the COVID-19 pandemic had a significant impact on the growth of the market.
Continuous manufacturing has been gaining traction in the market studied due to its potential to improve the quality and consistency of medication at lower costs. Furthermore, the adaptation of continuous manufacturing in the pharma industry and the rising demand for medication due to the growing prevalence of diseases around the world is likely to propel the market growth. Continuous manufacturing help manufacturers meet the market demand at the same time, which lowers the cost of manufacturing.
Moreover, technological advancements in manufacturing and support from government agencies are expected to bolster the studied market's growth. The increasing approval for continuous manufacturing is also expected to boost the growth of the market. For instance, in October 2021, the United States Food and Drug Administration (FDA) approved four drugs using continuous manufacturing, which included the first regulatory application using continuous manufacturing for an active pharmaceutical ingredient.
Additionally, the increasing collaborations by the market players are expected to drive the growth of the market. For instance, in September 2020, Emerson and Integra CMS collaborated to accelerate the adoption of continuous pharmaceutical manufacturing.
Thus the above-mentioned factors are expected to drive the growth of the studied market during the forecast period. However, the slow adaptation of continuous manufacturing, lack of regulatory, and technical clarity regarding guidelines may impede the market growth of the market over the forecast period.
Continuous Manufacturing Industry Segmentation
As per the scope of the report, continuous manufacturing refers to the manufacturing process of products without any interruption. It is the opposite of batch manufacturing. Continuous manufacturing is a method for manufacturing pharmaceutical products from end to end on a single, uninterrupted production line. The continuous manufacturing market is segmented by Product (Integrated Continuous Manufacturing and Semi Continuous Manufacturing), Application(API manufacturing, and End Product Manufacturing), End User (Contract Manufacturers, Pharmaceutical Companies and Other End Users), and Geography (North America, Europe, Asia-pacific, Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends of 17 countries across major regions globally. The report offers values (in USD million) for the above segments.
By Product | ||||||||
Integrated Continuous Manufacturing | ||||||||
|
By Application | |
API Manufacturing | |
End Product Manufacturing |
By End User | |
Contract Manufacturers | |
Pharmacuitical Companies | |
Other End Users |
Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
Global Continuous Manufacturing Market Size Summary
The continuous manufacturing market is experiencing significant growth, driven by its ability to enhance the quality and consistency of pharmaceuticals while reducing costs. The COVID-19 pandemic acted as a catalyst for this growth, as the surge in demand for pharmaceuticals highlighted the need for more efficient manufacturing processes. This has led to increased adoption of continuous manufacturing technologies within the pharmaceutical industry, supported by technological advancements and favorable government policies. The market is further bolstered by regulatory approvals and collaborations among key industry players, which are facilitating the broader implementation of continuous manufacturing practices. Despite these positive trends, challenges such as slow adaptation rates and regulatory uncertainties may pose obstacles to market expansion.
Regionally, North America is expected to maintain a significant share of the continuous manufacturing market, supported by advanced technological infrastructure and a strong presence of major market players. The region benefits from a favorable regulatory environment and substantial investments in research and development, particularly in the pharmaceutical and biotechnological sectors. Collaborative efforts among companies to integrate automation with manufacturing processes are also contributing to market growth. The competitive landscape is characterized by a limited number of manufacturers focusing on innovation and efficiency improvements. Overall, the continuous manufacturing market is poised for robust growth, driven by technological advancements, regulatory support, and strategic collaborations.
Global Continuous Manufacturing Market Size - Table of Contents
-
1. MARKET DYNAMICS
-
1.1 Market Overview
-
1.2 Market Drivers
-
1.2.1 Less Cost and Better Quality of Production
-
1.2.2 Support from Regulatory Authorities Around the World
-
-
1.3 Market Restraints
-
1.3.1 Lack of Regulatory and Technical Clarity
-
1.3.2 Slow adaptation and Rigidity Among the Industries
-
-
1.4 Porter's Five Forces Analysis
-
1.4.1 Threat of New Entrants
-
1.4.2 Bargaining Power of Buyers/Consumers
-
1.4.3 Bargaining Power of Suppliers
-
1.4.4 Threat of Substitute Products
-
1.4.5 Intensity of Competitive Rivalry
-
-
-
2. MARKET SEGMENTATION (Market Size by Value - USD million)
-
2.1 By Product
-
2.1.1 Integrated Continuous Manufacturing
-
2.1.2 Semi Continous Manufacturing
-
2.1.2.1 Continuous Blenders
-
2.1.2.2 Continuous Granulators
-
2.1.2.3 Continuos Coaters
-
2.1.2.4 Continuous Compressors
-
2.1.2.5 Continuous Dryers
-
2.1.2.6 Other Semi-continuous Manufacturing Products
-
-
-
2.2 By Application
-
2.2.1 API Manufacturing
-
2.2.2 End Product Manufacturing
-
-
2.3 By End User
-
2.3.1 Contract Manufacturers
-
2.3.2 Pharmacuitical Companies
-
2.3.3 Other End Users
-
-
2.4 Geography
-
2.4.1 North America
-
2.4.1.1 United States
-
2.4.1.2 Canada
-
2.4.1.3 Mexico
-
-
2.4.2 Europe
-
2.4.2.1 Germany
-
2.4.2.2 United Kingdom
-
2.4.2.3 France
-
2.4.2.4 Italy
-
2.4.2.5 Spain
-
2.4.2.6 Rest of Europe
-
-
2.4.3 Asia-Pacific
-
2.4.3.1 China
-
2.4.3.2 Japan
-
2.4.3.3 India
-
2.4.3.4 Australia
-
2.4.3.5 South Korea
-
2.4.3.6 Rest of Asia-Pacific
-
-
2.4.4 Middle East and Africa
-
2.4.4.1 GCC
-
2.4.4.2 South Africa
-
2.4.4.3 Rest of Middle East and Africa
-
-
2.4.5 South America
-
2.4.5.1 Brazil
-
2.4.5.2 Argentina
-
2.4.5.3 Rest of South America
-
-
-
Global Continuous Manufacturing Market Size FAQs
What is the current Global Continuous Manufacturing Market size?
The Global Continuous Manufacturing Market is projected to register a CAGR of 12.80% during the forecast period (2024-2029)
Who are the key players in Global Continuous Manufacturing Market?
Siemens, GEA Group AG, Glatt GmbH, Thermo Fisher Scientific and Scott Equipment are the major companies operating in the Global Continuous Manufacturing Market.